Piramal Pharma Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Piramal Pharma announced that USFDA has issued an Establishment Inspection Report (EIR) for the company's manufacturing facility located at Sellersville (USA) and the inspection has now been successfully closed by USFDA.

Piramal Pharma announced that the Annual General Meeting(AGM) of the company will be held on 30 July 2026.

Piramal Pharma has allotted 21 lakh equity shares under ESOP on 05 June 2026. Consequently, the paid up equity share capital has increased to Rs. 1,331,34,81,300 (consisting of 133,13,48,130 equity shares of face value of Rs. 10/- each).

Piramal Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 165.7, down 3.04% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.36% on the day, quoting at 23467.1. The Sensex is at 74624.13, up 0.48%.Piramal Pharma Ltd has gained around 3.37% in last one month.Meanwhile, Nifty Pharma index of which Piramal Pharma Ltd is a constituent, has increased around 1.87% in last one month and is currently quoting at 24214.25, down 1.23% on the day. The volume in the stock stood at 15.47 lakh shares today, compared to the daily average of 61.33 lakh shares in last one month.

The PE of the stock is 29.36 based on TTM earnings ending March 26.

Powered by Capital Market - Live News